Form 4: Twist Bioscience COO Sells Shares for Tax Obligations

Twist Bioscience's President and COO, Patrick John Finn, sold 17,606 shares of common stock to cover tax withholding obligations related to PSU vesting.

Summary

• Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a sale of common stock.
• The transaction involved the disposition of 17,606 shares of common stock on October 30, 2025.
• The shares were sold at a price of $31.4443 per share.
• Following this transaction, Patrick John Finn beneficially owns 268,674 shares of common stock.
• The sale was non-discretionary, mandated by the issuer to cover tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).

Sentiment

Score: 6

Explanation: The sentiment is slightly positive to neutral. While it's a sale of shares, the explicit explanation that it's a non-discretionary 'sell to cover' for tax obligations mitigates any negative interpretation that might arise from a discretionary insider sale. It indicates the vesting of performance-based awards, which is generally a positive for the executive.

Positives

• The sale was explicitly stated as non-discretionary, solely to cover tax withholding obligations related to PSU vesting, rather than a voluntary sale based on management's market outlook.
• The transaction is a routine event for executives receiving equity compensation, indicating the vesting of performance-based awards.

Negatives

• The sale resulted in a reduction of the insider's direct ownership by 17,606 shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ('PSUs').
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

Insider sales to cover tax obligations upon the vesting of equity awards are a common and routine occurrence across all industries for executives receiving stock-based compensation. This transaction is consistent with standard practices for managing equity compensation.

Stakeholder Impact

• Shareholders: The sale represents a minor, non-discretionary reduction in insider ownership, which is unlikely to significantly impact investor confidence or the company's stock price.
• Employees (specifically Patrick John Finn): The transaction allows the executive to fulfill tax obligations arising from vested equity compensation.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary 'sell to cover' transaction by an executive to satisfy tax obligations related to vested equity awards. Such transactions are common and do not typically signal a change in management's outlook or the company's fundamentals. Therefore, it does not provide new information that would warrant a change in an investment thesis, and a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Tax Withholding, PSU Vesting, Executive Compensation